Corticosteroids in Severe Community-Acquired Pneumonia: Could CAPE COD Catalyze a Change in Critical Care Management?
Critical Care Now
AUGUST 18, 2024
Reading Time: 2 minutes Article: Dequin P, Meziani F, Quenot J, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931-1941. PMID: 36942789. ClinicalTrials.gov: NCT025174897 Background: Community-acquired pneumonia (CAP) can lead to significant pulmonary and systemic inflammation, resulting in impaired gas exchange, sepsis, organ failure, and increased mortality.
Let's personalize your content